Order before 2:00 PM - your package will be shipped the same day!
Top Sellers
FLT3
FLT3 (Fms-Like Tyrosine Kinase 3): FLT3 is a receptor tyrosine kinase involved in the proliferation and differentiation of haematopoietic stem cells into mature blood cells. Mutations in FLT3, especially activating mutations, are commonly seen in acute myeloid leukaemia (AML) and are linked to poor prognosis. Targeting FLT3 with inhibitors is a therapeutic approach used to treat AML and other blood cancers with FLT3 mutations.
Description
Tests containing this item
190 genes
The GetTested DNA Immunity & Inflammation test reveals your genetic tendencies towards inflammation, autoimmune diseases, allergies, and infections. By examining genes linked to conditions like CRP (inflammation), psoriasis, and gluten sensitivity (celiac disease), as well as your response to common allergens and pathogens, it offers a deep dive into how your immune system functions.
₹ 16 110.00 INR
Trusted by over 100.000+ customers
The home test was incredibly simple to use, with clear and easy-to-follow instructions. The results were precise and well-explained. I also appreciated the option to get my questions answered about the results.
Ramesh Kumar
I found the home test process seamless and hassle-free. The instructions were straightforward, and the results were presented in a very professional and clear manner. Having the chance to clarify my doubts made it even better.
Priya Sharma
Using the home test was a breeze. The directions were easy to understand, and the detailed results were shared promptly. It was comforting to know that I could ask questions about the results and get quick responses.
Amit Joshi
The home testing kit was simple to use, and the instructions were clear. The detailed report was very informative, and I felt reassured by the opportunity to discuss the results with a professional.
Meena Iyer
The home test was well-designed and came with clear, step-by-step instructions. The results were detailed and easy to interpret. I also appreciated being able to ask follow-up questions about my report.
Vikram Singh